BELGRADE (Serbia), November 26 (SeeNews) – Serbia’s largest drug producer Hemofarm, owned by Germany’s STADA, has received approval for exports to the U.S. of an anti-inflammatory drug that would initially generate up to $20 million (15.4 million euro) in sales revenue annually, local daily Politica reported on Wednesday.
Jun 10, 2026
BucharestJun 30, 2026Marrakech
